Pellets of P were implanted subcutaneously into 2 months old mice BALB/c. The pellets contained 20 or 40 per cent of P mixed with cholesterol. Pellets containing 100 per cent of P also were used. Additional pellets were implanted every 3 months. In one of the groups with 100 per cent pellets of P implantation of additional pellets was made every 2 months. At the end of experiments the pellets are often found covered with a thin layer of tissue; the weight of a pellet lhaving remained for a long time in the body may be even greater than before. For the purpose of determining the total quantity of the steroid adsorbed the following procedure was used. All the removed pellets of a given group of animals were mixed together, dried, triturated and extracted repeatedly with ether. The quantity absorbed corresponds to the difference between the initial weight of the pellets and the quantity soluble in ether present in the removed pellets. For details of calculation with 20 or 40 per cent P pellets see former work (Fuenzalida. 1950; Fuenzalida and Lipschutz, 1953) .
Antiluteinizing action of progesterone
The antiluteinizing action of P acquires new interest when discussing the problem of P as a contraceptive; the inhibition of ovulation and luteinization by P is implicitly a contraceptive action. As well known, this indeed does not mean that all contraceptive steroids are acting in the same way as P. For an exhaustive summary on progesterone as an antifertility agent we refer to Pincus (1965) . Table I summarizes comparative observations on luteinization in normal aniimals and in animals receiving variable quantities of P. The antiluteinizing activity of P becomes evident in aged animals in experiinents with 29 ,ig./day of P.
The decline of frequency of corpora lutea in normal aged mice also is remarkable. In work with rats 20 out of 24 animals 607 to 1156 days old, i.e. 93 per cent of the group, still contained corpora lutea (Mandl, 1959) .
Absence of neoplastic ovarian changes in mice treated for 13 months with P In our former work with 19-nor-P treatment was in some animals for 13 months, i.e. the greater part of the reproductive life span. After the removal of the pellets tumours were found unexpectedly in one of these animals 47 days later and in 2 animals 227 days later (Lipschutz, Iglesias and Salinas, 1963, Tables 5  and 7 , animals 4, 6 and 7). Thus the first step made in our experiments with P was sacrificing a group of animals which had been treated with large quantities of P during 13 months.
The group was of 31 animals receiving 117 to 900 ,tg./day; the animals were killed after a treatment of 397 days. There was, in this group, not a single animal with corpora lutea (Table II) (Lipschutz, Panasevich and Cerisola, 1964; Lipschutz, Panasevich, Cerisola and Alvarez, 1964) . However, to facilitate classification in the present work it became necessary to make use of two additional notations: (1) not only " microtumour " but micro-I and micro-II, according to their size; and (2) proliferation of the germinal epithelium (PGE). These additional notations are necessary owing to the fact that the evolutional pattern of the granulosa-cell tumour (G) as induced by steroids-19-nor-P and now also P-is different from the evolutional pattern of G in intrasplenic, intrahepatic, intrarenal and intretesticular grafts. There is no transitional luteomatous phase due to the proliferation of cells as present in the ovarian stroma; the tiny micro-II start as G. The microtumours induced by 19-nor-P and so also by P, as already mentioned, always occupy a peripheral site. In some cases there is also a proliferation of the germinal epithelium (Fig. 5, 6 ). lndeed, these tiny structures are microscopically not coincident with the tiny micro-II tumours (Fig. 8. 16 ).
The index, in mm2, is the surface of the supposedly largest section of the growth. The determination of the index, as in former work, was made comparatively in two different ways: (1) by direct measurement beneath the microscope, and (2) by cutting the growth out of the photo and weighing it. With microtumours the results obtained in the two ways are more or less coincident, and the more rapid way (1) in general suffices. Both procedures are certainly far from being exact but they are very helpful for the orientation both of the worker and the reader. The indices of G tumours of different size, in mm2, are given at the top of Table III .
Results obtained in animals treated for 18 months with variable quantities of P are summarized in Table III ; some of these animals, indeed without any details, have already been mentioned in Table 11 .
A small micro-I was found also among the 33 normal animals (Fig. 3) . The comparative incidence of growths in 33 normal aged animals, and in 76 animals receiving 9 to 29 ,ug./day of P, is not significant; all the more as 2 out of the 5 cases in the 9 to 29 ,ug. groups are no more than tiny nodules of the proliferated Fig. 6 there is already a transitional condition from PGE to micro-II G. There was indeed in the 9 ,tg./day group also a micro-I G with an index of about 4 mm. but thus occupying almost the whole ovary (Fig. 4) . In the 29 ,ug./group there were besides PGE (Fig. 6 ) also 2 micro-II G (Fig. 7) .
With 59 pg./day the incidence of G increases considerably. No less than 7 out of 28 animals have G tumours: 1 macro G with an index of 9.5, 1 micro-I and 5 micro-Il G. The dimensions of two of the latter are somewhat larger than There is a further considerable increase when the available quantity of P reaches 117 ,ug./day: 2 macro G (Fig. 9, 10 ), 2 micro-I (Fig. 11 ) and 3 micro-Il). Somewhat different is the condition in the group with 665 ,ug./day. There were 4 micro-I (Fig. 12, 13 , 14) and 6 micro-II (Fig. 15, 16 ). In one of these micro-1I (Fig. 15) the order of the cells was as typical as in the macro G (Fig. 9B , lOB); another micro II (Fig. 16 ) was but a minute nodule similar to Fig. 8 . The differences between the 117 ,ug./day group and the 665 /ig./day group were the following: (1) there were in the 665-group no macro G; (2) there were in the latter 2 cases with bilateral microtumours (Fig. 14, 15) .
When comparing the 117 and 665 ,ug./day series one has the contradictory feeling that the neoplastic reaction taken as a whole has diminished with the considerable increase of P per day. This is indeed a very vague feeling. But the latter becomes stronger when comparing results with 665 and 900 ,tg./day. There were among 16 animals with 900 ,ug./day only 3 with G; all were micro-II (Fig. 17) . However, the structure of these 3 micro-II G was as ever coincident with that of macro G and micro-I G in the preceding groups.
One may ask whether the tumorigenic action of P goes parallel with the antiluteinizing one. When comparing Table III with Table I it might seem that some tumorigenic action becomes established before the antiluteinizing one is completed (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) ,ug./day). But as already insisted upon, the increase of tumour incidence in this group and in the following 29 ,tg./day group, compared to normal animals, is not significant. We shall also see in one of our next papers that in experiments with 19-nor-contraceptives G may appear when corpora lutea are still present.
Tumours appearing after the removal of progesterone pellets As already mentioned, tumours appeared in experiments with 19-nor-P a certain time after the removal of pellets which had been present in the body for 13 months. In our work with P pellets were removed after a treatment of 13 and 18 months. Results with 24 animals surviving for many months the end of the treatment are given in Table IV (la and 2a) .
In experiments with a treatment of only 13 months (la) and a long survival after the removal of the pellets there was one animal with a typical macro G with an index of 12. A micro-I was present in the second animal (Fig. 18) .
In 2a with a survival of various months after a treatment of 18 months the incidence was the same as in 2b, i.e. in animals killed at the end of the treatment. In other words, no increase of tumour incidence was obtained by increasing the age of the animals by 2-to 4-months. Thus it would seem that it is not the age which could be responsible for the differential results with a treatment of 13 and 18 months (lb and 2b); the difference seems to be due just to the duration of treatment. Indeed, age may be responsible for a more ample growth of G induced by P; this would explain both the appearance of a macro G in la and the unique picture of the trifocal growth in la and 2a ( Fig. 18 and 19 ). The question whether the difference between la and lb is significant and whether there is an after-effect of P is certainly of fundamental pathological interest and should be studied in a much greater number of animals.
DISCUSSION
There is no doubt that the prolonged administration of P can produce ovarianl granulosa-cell tumours in mice. The question how far the incidence might depend on spontaneously occurring G in this or in other strains is of no avail because the experiments related in this paper give full evidence that the incidence of G increases (1) with the quantity of P administered, and (2) with the duration of treatment with P. In our work the administration of P was a continuous one; it is but reasonable to raise the question how far the continuity of the action of P might have contributed to the results obtained. The question is of considerable interest when discussing the tumorigenic faculties of steroids; the fibromatogenic action of oestrogens fails when the latter are administered rhythmically, i.e. discontinuously (Lipschutz, Rodriguez and Vargas, 1941; Lipschutz, 1950, pp. 40-41) . Our results give full evidence that the neoplastic faculty of P is greatly inferior to that of 19-nor-P. Even with 117 ,Ig./day administered during 18 months the tumorigenic result is less pronounced than with 15 ,tg./day of 19-nor-P administered during 13 to 17 months. Thus one may argue that it was truly the " Wisdom of the Body ", to use the words of Cannon (1932), giving preference to P and not to the more active 19-nor-P; any quantitative or timing lapse would mean in the case of the latter a considerable danger for the ovary. Granulosa-cell tumours have been produced experimentally grafting the ovary into the spleen in rats (Biskind and Biskind, 1944) , in mice (Li and Gardner, 1947; Gardner, 1955 Gardner, , 1961 Furth and Sobel, 1947) , in guinea-pigs (Mardones, Iglesias and Lipschutz, 1955; summaries Lipschutz, 1950 summaries Lipschutz, , 1957 , and in rabbits (Peckham, Greene and Jeffries, 1948; Peckham and Greene, 1952) . The evolution of these experimental ovarian tumours in mice and guinea-pigs also has been studied and summarized by various authorities (Guthrie, 1957 (Guthrie, , 1959 Kullander, 1954 Kullander, , 1956 Kullander, , 1959 Lipschutz, 1957 Lipschutz, , 1960 Lipschutz, , 1963 Lipschutz, Rojas, Cerisola and Iglesias, 1960; Lipschutz, Panasevich, Cerisola and Alvarez, 1965) . The final structure of G induced by 19-nor-P or by P is apparently coincident with that of G in intrasplenic grafts. However, the evolution of G originating under the influence of 19-nor-P or P is fundamentally different from that of G originating in intrasplenic ovarian grafts. In intrasplenic ovaries the growth originates in the overwhelming number of cases from cells as present in the ovarian stroma; the growth is primarily a luteoma which subsequently changes into G. On the contrary, the growth arising under the influence of the mentioned steroids is from the start a granulosa-cell tumour located, when still a microtumour, in the periphery or even on the surface of the ovary.
Since there is in some cases a proliferation of the germinal epithelium the question arises whether the latter partakes in the evolution of these steroid-induced granulosa-cell tumours. One will remember that according to Gardner (1955) even the granulosa-cell tumours in the intrasplenic grafts " appeared to arise from the germinal epithelium " (p. 116). Indeed, most of those who have worked with intrasplenic grafts were rather in favour of the cells of the stroma or of the theca being the matrix of the growth in intrasplenic ovarian grafts (Kullander, 1959; Guthrie, 1957; Lipschutz, 1960) . The same seems to be true also for the microtumours originating in the kidney and the liver (Lipschutz, Panasevich and (erisola, 1964) .
The implication of P in tumorigenesis has been known for several years; evolution of mammary cancer in rats treated with a carcinogen is enhanced when P is added (Cantarow, Stasney and Paschkis, 1948; Huggins, Briziarelli and Sutton, 1959) . More recently the question has been re-examined in mice bv Poel (1965) with impressive results. There is no doubt that P may act as a potent co-carcinogen for mammary cancer when administered together with methylcholanthrene; incidence of the mammary tumour as induced by the carcinogen was 21 per cent but increased to 100 per cent when P was given simultaneously (Poel, 1965, p. 827) . In the work of Poel, in mice no more than 2-5 ,ug./day of P in peanut oil were administered. In former work in rats more than 200 /ug./day were injected intramuscularly (Cantarow et al., 1948, p. 412) , or about 25 to 30 ,ug./day when calculating for mice. On the other hand, our work gives full evidence that under certain quantitative and timing conditions P mav produce ovarian tumours independently from any carcinogen. The tumorigenic quantities of P in absence of any carcinogen are indeed several times greater than those used in the work of the mentioned authorities.
Most interesting clinical work has been done using 17ax-hydroxyprogesterone capronate in the treatment of malignant tumours of the breast, ovary and uterus, with success in a number of cases (Jolles, 1962) . At first sight this seems contradictory to the findings both of the mentioned authorities and of ours. It is of considerable interest to approach these problems from a quantitative point of view. Jolles administered to his patients 250 mg. of 17Lx-hydroxyprogesterone capronate weekly by injection for up to 3-years. This quantity administered to patients corresponds to about 600 ,ug./day per 1 kg. of body weight, i.e. to about 20 pg./day in mice. A quantitative comparison with continuous absorption of P from subcutaneously implanted pellets would be difficult since the capronate of 17a-hydroxyprogesterone is more active than P. Landau, Ehrlich and Huggins (1962) administered to patients with advanced mammary cancer 50 mg./day of P intramuscularly, i.e. about 30 ,ag./day when calculated for mice. This quantity is not yet tumorigenic in mice (see our Table III) . But here again comparison is rendered difficult because in this clinical work 5 mg. of oestradiol were given simultaneously with the mentioned 50 mg. of P. Certainly in none of these clinical studies was the treatment so prolonged as in our mice with 13 or 18 months when P becomes tumorigenic. SUMMARY Granulosa-cell tumours are induced in the ovary of mice with the prolonged and continuous administration of progesterone.
The production of these tumours depends on the quantity of progesterone administered and on the duration of this administration.
The incidence increases with the amount of progesterone administered. The neoplastic faculty of progesterone is probably ten times smaller than that of 19-nor-P.
The evolutional pattern of the steroid-induced granulosa-cell tumour is different from that of the same tumour originating in intrasplenic grafts:
(1) The steroid-induced ovarian tumour is from the start a granulosa-cell tumour whereas in grafts the same tumour is preceded by a luteoma arising from the proliferation of cells as present in the ovarian stroma.
(2) The steroid-induced granulosa-cell tumour arises in the periphery of the ovary and one cannot avoid questioning whether, besides the follicle, also the germinal epithelium partakes in this neoplastic proliferation.
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